This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
home:arf:timeline [05.25.2013] – [Timeline of the Marshall Protocol] update of title for Amy joyful | home:arf:timeline [09.14.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== Timeline of the Marshall Protocol ====== | + | ====== Timeline of the Marshall Protocol |
Line 5: | Line 5: | ||
**1974** – Teaching in Papua New Guinea, Trevor Marshall experiences tropical sun - an experience which would prove crucial twelve years later. | **1974** – Teaching in Papua New Guinea, Trevor Marshall experiences tropical sun - an experience which would prove crucial twelve years later. | ||
- | **1978-1982** – Marshall works towards his PhD thesis | + | **1978-1982** – Marshall works towards his PhD thesis. His work includes |
**1981** – While a Visiting Scientist in the Dept. of Surgery at Toronto' | **1981** – While a Visiting Scientist in the Dept. of Surgery at Toronto' | ||
- | + | ||
- | **1984** - Marshall' | + | **1984** - Marshall' |
**1986** – Standing in a city square in Stockholm, nearly the most northerly capital in the World, Marshall' | **1986** – Standing in a city square in Stockholm, nearly the most northerly capital in the World, Marshall' | ||
Line 17: | Line 17: | ||
**1999** – Marshall learns that other patients with sarcoidosis who were administered Angiotensin Receptor Blockers (ARBs) often developed a neurological reaction. Marshall starts a sabbatical in early 2001 in order to further investigate this reaction. | **1999** – Marshall learns that other patients with sarcoidosis who were administered Angiotensin Receptor Blockers (ARBs) often developed a neurological reaction. Marshall starts a sabbatical in early 2001 in order to further investigate this reaction. | ||
- | **2001** - Marshall submits paper explaining that sarcoidosis could have a bacterial pathogenesis. Three revisions of the paper are rejected by the journal //[[http:// | + | **2001** - Marshall submits paper explaining that sarcoidosis could have a bacterial pathogenesis. Three revisions of the paper are rejected by the journal // |
**2001 March** - The first early adopter, Elaine Emmi, begins the use of an ARB to treat her sarcoidosis. | **2001 March** - The first early adopter, Elaine Emmi, begins the use of an ARB to treat her sarcoidosis. | ||
- | **2001 December** - Nilsson //et al.// publish article in //Journal of infectious disease// showing that deceased sarcoidosis patients contain the genetic material from // | + | **2001 December** - Nilsson //et al.// publish article in //Journal of infectious disease// showing that deceased sarcoidosis patients contain the genetic material from // |
- | **2002 March** – Marshall registers | + | **2002 March** – Marshall registers |
- | **2002 May** – Marshall changes to using the ARB olmesartan (Benicar). | + | **2002 May** – Marshall changes to using the ARB olmesartan |
- | **2002 August** – Trevor Marshall and Frances (Liz) Marshall publish NetPrint, "[[http://clinmed.netprints.org/ | + | **2002 August** – Trevor Marshall and Frances (Liz) Marshall publish NetPrint, "// |
- | **2002 September** – " | + | **2002 September** – //Remission in Sarcoidosis// is published (in summary) at Mercola.com. Later that month, early adopter (and colleague) Belinda Fenter commences pulsed minocycline. |
**2002 December** – Early adopter (and colleague) Meg Mangin commences pulsed tetracycline. | **2002 December** – Early adopter (and colleague) Meg Mangin commences pulsed tetracycline. | ||
- | **2003 January** – A meeting with Dr. Alan Cantwell brought to light papers by Lida Mattman.(({{pubmed> | + | **2003 January** – A meeting with Dr. Alan Cantwell brought to light papers by Lida Mattman.(({{pmid> |
- | | + | |
- | **2003 January** – Mangin changes to minocycline and commences concurrent olmesartan. Fenter also commences using olmesartan. They are joined by Ms. Dale Thurlow, and Marshall' | + | **2003 January** – Mangin changes to minocycline and commences concurrent olmesartan. Fenter also commences using olmesartan. They are joined by Ms. Dale Thurlow, and Marshall' |
**2004 April** – Autoimmunity Research Foundation is founded. | **2004 April** – Autoimmunity Research Foundation is founded. | ||
- | **2004 June** – Trevor Marshall and Frances (Liz) Marshall publish " | + | **2004 June** – Trevor Marshall and Frances (Liz) Marshall publish " |
**2004 July** – Marshall speaks at 4th International Congress on Autoimmunity in Budapest. | **2004 July** – Marshall speaks at 4th International Congress on Autoimmunity in Budapest. | ||
- | **2004 July** – Marshall registers [[http:// | + | **2004 July** – Marshall registers [[https:// |
- | **2004 December** - The Journal of the Interregional Clinical-Diagnostic Center, Kazan, Russia, (ISSN: 1726-6149) publishes, in Russian translation, | + | **2004 December** - [[https:// |
**2005 March ** – ARF's ' | **2005 March ** – ARF's ' | ||
- | **2005 June** - Marshall publishes the English text of the Russian paper "[[http:// | + | **2005 June** - Marshall publishes the English text of the Russian paper "// |
- | **2005 July** – Marshall files for [[http:// | + | **2005 July** – Marshall files for [[https:// |
- | **2006 January** – Trevor Marshall, Robert Lee, and Frances (Liz) Marshall [[home: | + | **2006 January** – Trevor Marshall, Robert Lee, and Frances (Liz) Marshall [[home: |
**2006 March** – As part of Visiting Professor Lecture Series, which is organized by the FDA's Center for Drug Evaluation and Research, Marshall presents on " | **2006 March** – As part of Visiting Professor Lecture Series, which is organized by the FDA's Center for Drug Evaluation and Research, Marshall presents on " | ||
Line 63: | Line 63: | ||
**2006 June ** – Recovering from Chronic Disease: Sarcoidosis, | **2006 June ** – Recovering from Chronic Disease: Sarcoidosis, | ||
- | **2006 July** – Marshall files for [[http:// | + | **2006 July** – Marshall files for [[https:// |
**2006 July** – Marshall presents poster at Days of Molecular Medicine, the first of three such annual presentations, | **2006 July** – Marshall presents poster at Days of Molecular Medicine, the first of three such annual presentations, | ||
Line 71: | Line 71: | ||
**2007 July** – Marshall presents abstract at Metagenomics 2007, " | **2007 July** – Marshall presents abstract at Metagenomics 2007, " | ||
- | **2008 February** – Marshall publishes in // | + | **2008 February** – Marshall publishes in // |
**2008 September** – Marshall chairs session on vitamin D at International Congress on Autoimmunity in Porto, Portugal. Invited speakers for the session include Autoimmunity Research Foundation' | **2008 September** – Marshall chairs session on vitamin D at International Congress on Autoimmunity in Porto, Portugal. Invited speakers for the session include Autoimmunity Research Foundation' | ||
Line 83: | Line 83: | ||
- | {{tag> }} | + | {{tag> |
+ | < | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
+ | |||
+ | //broken links// | ||
+ | " | ||
+ | |||
+ | // | ||
+ | |||
+ | [[https:// | ||
+ | |||
+ | [[https:// | ||
+ | [[https:// | ||
+ | " | ||
+ | |||
+ | " | ||
+ | |||
+ | [[https:// | ||
+ | |||
+ | |||
+ | ===== References =====</ | ||
- | ===== References ===== |